Takeda San Francisco is expanding its antibody center of excellence, providing out-standing opportunities for career development and job satisfaction in a new state-of-the-art facility. If you wish to join our team of highly qualified people with a shared passion for biologics, then we urge you to explore Takeda San Francisco.
Takeda San Francisco, Inc.(TSF) is Takeda's global center for excellence for biologics. TSF was established in November 2007 and supports Takeda's therapeutic antibody research through our antibody technology platform. This platform is based on discovery, optimization and development technologies used to efficiently generate Investigational New Drug (IND) candidates for the treatment of cancer, inflammatory and metabolic diseases.
Takeda Pharmaceutical Company Limited is Japan's largest pharmaceutical company, and is the world-leader in oral diabetes medicines.